Silexon AI

Silexon AI is a biotechnology company that leverages artificial intelligence to revolutionize the discovery and design of both small molecule and macromolecule therapeutics. The company's proprietary platform integrates advanced machine learning algorithms with structural biology and wet-lab validation to address traditionally undruggable targets. Silexon AI focuses on high-value therapeutic areas including oncology, immunology, and infectious diseases. By streamlining the lead optimization and candidate selection processes, the company aims to significantly reduce the time and cost associated with early-stage drug development. Silexon AI operates through a hybrid model of internal pipeline development and strategic partnerships with global pharmaceutical firms.